NICE Turns Down Lucentis (Ranibizumab) For Diabetic Macular Edema Treatment, UK
NICE (National Institute for Clinical Excellence) in the UK has decided not to recommend Lucentis (ranibizumab) for diabetic macular edema (British spelling: oedema) treatment. NICE approves or turns down treatments that will be covered by the NHS (National Health Service), the UK's universal health care system...